
We will all learn to live with this illness, Chronic Myelogenous Leukemia, that is in one of us.
I hope to share the journey with others and to make a difference along the way.

Wilbur donated bone marrow through the National Marrow Donor Program, which operates the Be The Match RegistrySM. This is his story.
The opportunity to pay back
My wife works for the post office, and this was how we became involved. (Editor's note: The United States Postal Service's long partnership with Be The Match has added more than 47,000 donors to the marrow registry.)
But the reason for my donation goes back to before I was born. It hit me like a brick wall when I got the call to possibly be a bone marrow donor:
I've finally found a way to repay the person who not only gave me life, but also saved my life very early on.
My mother's choice
While pregnant with me, my mother was told she had developed a form of cancer. The doctor told her she could treat the cancer but the baby wouldn't live through the treatment, or she could bring the baby to full term but she would die because the cancer would be too far along. Without pause, my mother decided the baby would live.
As it turned out, the doctor was wrong and my mother didn't have cancer. Had she decided to have the treatment, I wouldn't have been born. Service to others, putting them first before her own needs -- that's how my mother, Mary E. Baughn, lived her life. (After 74 years and two bouts with cancer, Mary passed from this life to her heavenly reward.)
My choice
Second thoughts about doing this? Never entered my mind!
I hate needles and my family knew this. They all wondered how I would go through the "pincushion" phase.
Well, it wasn't that bad. I really never had a lot of pain, even after the marrow collection procedure.
Everyone I talked to at the National Marrow Donor Program, especially my contact person Cindy Hofkes, made me feel like I was the only person they were dealing with. The donation procedure at Miami Valley was a breeze, thanks to all the wonderful people there.
Only a few people get a chance to possibly save a life. Sign up! Be a match!
Luz donated bone marrow through the Be The Match RegistrySM. (Luz is shown with her husband, Santiago, and daughters, Gloria and Grace, who all supported her through the donation process.)
Luz's donation story:
I decided to join the registry when our church was looking for a match for one of our pastors. I joined in the summer and by October of the same year I received a letter stating that I was a possible match for a patient.
Help save a life this holiday season
You may not be called as a donor this holiday season, but you can still make a difference. Here are three things you can do today:
| 1. | The easiest gift: Tell at least 5 friends how they can save a life. |
| 2. | Add a note to your holiday letters about your commitment to Be The Match and the opportunity to save a life. |
| 3. | Help us raise $1 million for patient assistance so more patients like Joey Stott can focus on healing. |

Dr. Brian J. Druker, 54, an oncologist at Oregon Health and Sciences University and a Howard Hughes Medical Investigator, is one of three winners this year of the Lasker-DeBakey Clinical Medical Research Award, often called the “American Nobel Prize.” Dr. Druker shared the honor with Nicholas B. Lydon, a former researcher for Novartis, and Charles L. Sawyers of Memorial Sloan-Kettering Cancer Center, “for the development of molecularly targeted treatments for chronic myeloid leukemia, converting a fatal cancer into a manageable chronic condition.” Here is an edited version of a conversation that took place last month in New York:

Q. WHAT WAS LIFE LIKE FOR PEOPLE WITH CHRONIC MYELOID LEUKEMIA, OR C.M.L., PRIOR TO YOUR RESEARCH?
A. Life was pretty miserable. If you were over 40, the main therapy was interferon, which prolonged life for maybe a year in perhaps 20 to 30 percent of patients. Interferon made the patients feel awful — like the worst flu. The only other hope was a bone-marrow transplant for younger patients. The problem there was that the death rate in the first year was 25 to 50 percent.
C.M.L. patients were always difficult to see because both of us knew that the clock was ticking and there was virtually nothing that we could do about it.
Q. It must have been depressing to be an oncologist under those circumstances.
A. When I started my training in the 1980s, you rarely cured people. You felt, “if I can give my patient extra time, I’ve been successful.” But I could see there was a transformation of cancer treatment on the horizon thanks to breakthroughs in biochemistry and genomics. I wanted to be part of that, which is why I was a physician-researcher.
The way I’d been trained, cancer was seen as something like a light switch that was stuck in an “on” position. You were given a baseball bat, which was chemotherapy, and told to knock the light out with the bat. I thought, “Why don’t we just try to figure out why the light is stuck on, then we can fix it without breaking everything.”
So I started my laboratory career studying the regulation of cell growth — what turns the switch on, what helps it shut down. And that’s how Gleevec is different from earlier chemotherapies, which basically poisoned every cell in the body in an attempt to kill the cancer. Gleevec turned off the light switch and only killed the cancer cells.
Q. How did the idea behind Gleevec first come up?
A. By the late 1980s, C.M.L., though rare, was a cancer that scientists knew a lot about. We knew, for instance that a chromosomal abnormality existed in every C.M.L. patient. We knew that this abnormality created an enzyme that caused the uncontrolled growth of cancer cells. If you put this enzyme into animals, they got leukemia.
So in 1988, Nick Lydon, who led a drug discovery group at a pharmaceutical company that eventually became Novartis, came to talk to me. He was interested in developing drugs to block a family of cellular enzymes implicated in several cancers. I said to him: “If you want to develop targeted chemotherapies, C.M.L. is the disease to study. We know the most about it — and, if we can figure out a way to block this enzyme, we can turn off the cancer switch.”
So in Nick’s lab at the pharmaceutical company, he began screening for agents that worked on C.M.L. He’d send me his best compounds. I found one, STI571, that was better than the others; it would kill every C.M.L. cell in a petri dish. By 1995, STI571 was a lead compound set for clinical development.
Q. So Gleevec was on its way?
A. Not quite. Gleevec was a completely different class of drugs than what was used against cancer. Most researchers thought it wouldn’t work. Then, in 1996, before we were about to go to trials, Nick’s company merged with another, and he left. Gleevec was now caught in the changeover. I lobbied with the new executives. After some ambivalence, they agreed to go forward with Phase 1 trials. I think they felt it wouldn’t work and they could get rid of us afterwards.
But during clinical trials we saw this miracle: Once the patients were up to effective doses, we got a 100 percent response rate.
Q. Had that ever happened before in a clinical trial?
A. No. Never. You’d see patients where interferon wasn’t working, and they’d been issued a death sentence. Suddenly, all their hopes for the future were restored, and, with minimal side effects! This was around 1999, and the Internet chat rooms were just beginning. Patients in the trials began talking to each other like they’d never done before. I’d see a patient, and I’d read about it on the Internet that night: “few side effects,” “100 percent response.” Patients would come to me and say, “My doctor has never heard of this drug.” I’d never written it up. I hadn’t presented the data. Their doctors thought I was a charlatan. For a lot of people, Gleevec was simply too good to be true. But these once-dying patients were getting out of bed, dancing, going hiking, doing yoga. The drug was amazing.
Now the drug company had to make another decision. They hadn’t made enough drugs for a large-scale Phase 2 trial. But patients knew about Gleevec, and many more wanted to be included in the trials. Through the Internet, they generated a petition that landed on the C.E.O.’s desk, asking for greater access. That’s how Phase 2 was rapidly expanded.
Q. YOUR FRIEND AVICE MEEHAN OF THE HOWARD HUGHES MEDICAL INSTITUTE SAYS THAT YOU HAVE THE MOST AMAZING PERSEVERANCE. IS THAT WHAT IT TOOK TO MAKE GLEEVEC HAPPEN?
A. I think I’m more perseverance than smarts. There’s a basketball player who says, “Hard work beats talent when talent doesn’t work hard.” Well, I work hard. I understood that this project was too good to give up on. My patients needed me to do something to help them. I did everything I could by getting them a drug I thought would work.
When the drug looked like it was finally going to be approved, I was interviewed by a reporter from People magazine, Alexandra Hardy. She asked, “Who are your good friends?” I said: “I don’t have any. I work, eat, sleep, go to the gym.” She said: “You’re pathetic. You’ve got no balance in your life.”
Well, there is now. Alexandra and I got married, and we have three wonderful children.
Q. Gleevec was ultimately proved effective against two cancers, right?
A. Ten. It’s now F.D.A.-approved for 10. Gleevec went to market for a small disease, 50,000 patients, and it later got tested for other things. It’s now used by 200,000 patients worldwide.
Q. Do you see any of that?
A. I don’t see a penny, though that never was an issue for me. When I obtained the compound, it was already patented. I wasn’t going to get to test it if I tried to put my mark on it. I wanted to work on it because I thought it was going to be the way to treat C.M.L.
You know, my patients were people who’d been told “to get their affairs in order” because they were going die soon. And now some of them play with grandchildren they’d thought they’d never live to see. That’s worth more than money.
----------------------------------------------------------------------------------------
What a man Dr Druker is. Every time I look at Steven, it's because of Dr Druker...... It's as simple as that. I would not be seeing my child, if not for him. Thats incredible, humbling and creates a depth of love for this man that goes beyond anything 'normal'.
This article made me realize again just how tenuous life is, how one man stood between my life now and a life that would have been just unimaginable....
Thank you, Dr Druker........ thank you!
love and light
Annie
.jpg)

.jpg)









And so I find myself relaxed, quiet and peaceful and playing with some of my photographs again. This sunrise really sang to me today and I thought of Nick and Diane and family who are struggling really hard to fight off the effects of cml. I wish them all the peace and the quietness that this picture conjures, and then tons more. 
Jackson Adjunct Professor Shaoguang Li, M.D., Ph.D., who now has a laboratory at the University of Massachusetts Medical School in
In research published in the journal Nature Genetics, the researchers also showed that an asthma medication for human patients is an effective treatment for CML in mice.
The gene, Alox5, processes essential fatty acids to leukotrienes, which are important agents in the inflammatory response. But according to the researchers, Alox5 has a more sinister side. It is vital to the development and maintenance of cancer stem cells.
Cancer stem cells are slow-dividing cells that are thought to give rise to a variety of cancers, including leukemia, and to be critical for maintaining them. Researchers theorize that cancer stem cells must be targeted for effective treatment of many cancers, but direct evidence is still lacking.
The researchers found that CML did not develop in mice without Alox5 because of impaired function of leukemia stem cells. Also, Alox5 deficiency did not affect normal stem cell function, providing the first clear differentiation between normal and cancer stem cells.
Li also treated mice with CML with Zileuton, an asthma medication that inhibits the Alox5 inflammation pathway, as well imatinib, commonly known as Gleevec, the most effective current leukemia medication. Imatinib effectively treated CML, but Zileuton was more effective. The two drugs combined provided an even better therapeutic effect.
The Jackson Laboratory is seeking patent protection on the novel approach to treat CML that Li and colleagues have demonstrated.
The exact mechanism for the Alox5 gene in regulating the function of leukemia stem cells but not normal stem cells needs further study, but it appears that the two types of stem cells employ different pathways for self-renewal and differentiation. The findings provide a new focus of study into how leukemia stem cells are distinct from normal stem cells and how they can be targeted in cancer therapies. A future clinical trial targeting Alox5 will provide the first anti-stem cell strategy in cancer therapy. It is likely that other cancer stem cells will have specific pathways that also differentiate them from their normal stem cell counterparts.
###
Li conducted the research primarily at The Jackson Laboratory, with collaborators at
The Jackson Laboratory is an independent, nonprofit biomedical research institution based in



Chronic myelogenous leukaemia (CML) was long-considered one of the deadliest forms of cancer, capable of striking at any time, causing extreme pain and worse still, affecting both adults and young children. Before the work of two pioneering medical researchers, a diagnosis of CML and subsequent attempts at treatment guaranteed prolonged pain and no certainty of remission. But now with Glivec, a cancer fighting drug with a 98 percent remission rate, CML has lost much of its former bite thanks to American oncologist Brian Druker and Swiss medicinal chemist Jürg Zimmermann.
Inventor(s): Jürg Zimmerman, Brian Druker
Invention: CML Treatment (marketed as Glivec)
Sector: Healthcare
Company: Novartis
In 1960, researchers identified an abnormally short chromosome in 95% of patients with CML, which they named the Philadelphia chromosome. Understanding the phenomenon of the Philadelphia chromosome was seen as the key to curing CML. After another 13 years of research, it was discovered that the Philadelphia chromosome is the result of two chromosomes swapping DNA.
By the early 1980s, researchers demonstrated that the DNA swap resulted in a fusion protein (the product of two genes or proteins joining together) called BCR-ABL. BCR-ABL causes the overproduction of white blood cells in the body. Where healthy blood contains 4,000 to 10,000 white cells per cubic millimetre, blood from a CML patient contains 10 to 25 times this amount.
In 1990, researchers began looking for BCR-ABL inhibitors and at Novartis, a phamaceutical company based in Switzerland, scientist developed a compound designed to reduce BCR-ABL. Jürg Zimmermann and his team set about improving the compound, eventually creating a potent and specific BCR-ABL inhibitor.
In 1994, Novartis teamed with Brian Druker and set about refining and readying the inhibitor for clinical trials that began in 1999. Today, the compound now known as Glivec is being hailed as something of a wonder drug. Follow-up data show that Glivec therapy helped 98% of patients in chronic-phase CML stabilise their blood counts.
Moreover, in 92 percent of cases, the Philadelphia chromosome was completely disabled, though still present. Patients treated with Glivec followed by a bone marrow transplant, a common course of treatment for CML, experienced a cure rate of 60-80%. Side effects of Glivec tend to be mild and easily manageable, with less than 5% of patients experiencing serious adverse effects.
Thanks to the Zimmermann-Druker partnership, the resources at powerhouses like Novartis and the tireless work of other medical researchers, it seems suddenly possible that a cure for cancer may indeed be found in our lifetime.

This is incredible hope! I hold on to it every day even though Steven is doing so very well. I am absolutely thrilled by Dr Druker's dedication to finding a cure for CML. It humbles me tremendously to think that every hour he is thinking about or working on the cure, he is doing this for my kid. I really don't know that there are enough ways to thank this man.
This was an perfect article for me to find and read today, on Mother's Day. Apart from all the flowers, chocolates, cards and phone calls from my three chickens and others - this added that extra light.
I hope all mothers had a wonderful day, felt treasured and loved and appreciated. I certainly did.
love and light,
Annie
Time flies and so many things are going on right now - all good.. but I am only getting to posting Steven's PCR results now - almost a week after they came in! Amazing how time changes things.
So many things swirl through my mind and I wonder sometimes at the wisdom or need to write them down. Many of these thoughts disappear into the days that are screaming past and other keep swirling around the back of my mind.
Two years ago, this little sprite, my youngest grand daughter arrived to brighten our days... and she has done her job really well. She is a pure delight, gorgeous, cute and just plain beautiful too...... Happy Birthday, McKenzie!




This is Dawn. A beautiful young lady, bright, energetic, loving and so incredibly full of life. She made a difference in so many people over many years, and deeply so this past year. Her blog is brimming over with people who's life she has changed in some way or another..... go and read it - it's truly humbling. http://www.goshdawnit.com/.
This picture made me think about how life is. It's full of reflection, chaos in places and calm and quiet in others. There are parts in sunshine and others in deep shadow. There are reactions to actions that we often don't see without looking carefully and closely and so often this all happens in the short time it takes to throw a handful of stones - only seconds. And once the water calms down again, it will look all the same - but its not. There are a few more heavy stones in this pond. This is life.
Bye Bye RoadrunnersUSA.com
Today was sort of sad in a way, but also the right thing and the right timing. Today I decided to let go the website I put together right after Steven was diagnosed. We did this fundraiser - somewhere around 11 000 miles from Tennessee to Alaska and back, to try to raise money for the Leukemia and Lymphoma Society. We had an incredible time, the people we met are still embedded deeply in my heart and its a trip I will never forget for so many reasons.
But, it's time to let the site go. Those very intense, terrifying days have passed and now my days are more like those beautiful colored pieces of glass one finds on the beach sometimes, with rounded edges and the sun making them glint. I am ok in letting this go now, but am putting it on this blog so that I have a record of what it looked like.
In no way was it a professional website but it was my first. And I guess the first of anything always holds a special place in one's heart - this one especially so.
Those were incredible days - terrifying, alive and so amazingly full of love, so intense, so aware and deep.. I wonder if there is a way to be so alive without some horrible diagnosis getting there first?
And once more, Thank You to everyone that was there for us in those days as well as these. Penny was such a part of that journey - I miss her. I have so many wonderful memories from that time... and a deep and wonderful gratitude.
Love and Light
Annie
oh well - only half of it will fit into the blog - but thats ok....it's enough to remind me :)















November is National Marrow Awareness Month. Otsuka America Pharmaceutical, Inc., has provided an unrestricted grant to cover the cost of tissue-typing tests for potential donors who join online.
This is your chance to join for FREE. What are you waiting for?
Oh boy - where do I start........ Saturday was a day that had an incredible number of different feelings surrounding it way before it started! By Thursday evening deep disappointment had replaced any nervousness. I had called everyone on the list of people who had voluntarily signed up and only one guy said he would make it to the drive! I was so terribly disappointed and sad too that it appeared that the day would be a waste of time.
I read late into the night on Friday so that my mind would not keep on working long after the light went off, like the night before. And it worked - I slept better than any baby ever has..... On Saturday morning the sun literally shone so brightly that it felt as if the light was being forced into my brain. I smiled and knew it would all be ok, no matter what. By then I knew that my daughter, Lisa and her husband would be up here and they were both going to join the registry and my sister Kate too - and that already tripled the ‘only one extra person’ idea.
And so the day started on a much better note than the day before. The Vein Voyager Blood bus arrived at around 11.30am with five very lovely, very capable young ladies with what appeared to be an unlimited supply of smiles and gentleness. And Alta, the “Marrow Lady” arrived and set up her table full of forms, pamphlets and papers inside.
Dawn and Greg from Carolyn’s Hope arrived with Tyler, their six year old son - it was absolutely wonderful to have them as back up all day long! They both had wanted to get on the Marrow Registry and donate blood and had waited for this drive to do so - awesome :) A big thanks to both of you for everything - we really appreciate you and I hope that next time we have more time to sit down and chat.
Steven and Laura stopped by in a quiet time and I introduced him to those that were there and all the ladies in the Vein Voyager too. I wonder just how deeply I embarrass this son of mine at times, but they did not run off quickly and after a while I told them to head out and get on with their day. He is so good and gentle with me when I get on a roll and 'show him off' - its just lovely.
Right here I must put in a REALLY big Thank You to the ladies of Kays Kastles. Their premises were perfect for the drive and the atmosphere was all open and sunny and bright. They helped me on every level they could and were just simply great!
Slowly people trickled in, and the one little dark cloud that thundered by was because my sister Kate was royally ticked off as her iron was too low to donate blood! But she did sign up on the marrow registry, which sent that cloud back into oblivion. A good many people who donated blood also signed up on the registry which was double wonderful. It was absolutely awesome to see people hunched over forms, spending their time and effort to make themselves available to possibly save a life.
I tried to talk to every one of the new members of the Marrow Registry and tell them how much I appreciate their willingness to help. All of those that I spoke wished so hard that they would ‘be picked’ to be a donor. They all said that it would be incredible and an absolute honor.
I had hung a good many photos on the wall.... these were of people who are dealing with cancer in some form or another and sadly two photos were in memory of people who are no longer here with us - Adrian from the UK and Carolyn, Greg’s mother who could not find a match. Another of the photos was of Dawn, a young lady who needs a marrow donor but has not yet found a match. When the local tv news guy came up and I told him the stories of those on the wall - he immediately zoned into Dawn’s photo and it was she who got on our local news later that night. I had written on her photo that she needs a donor. I so hope and wish that Saturday will help her.
To see a face of someone so young and beautiful, with a sparkle in her eyes and yet fighting such a tough battle really put meaning into the drive. I know what I saw in the eyes of those that looked at her - determination to do what they could to help either her or others in the same situation.
All those photos made the donor drive come alive. All of you sat there with us with pride, a sense of humor and determination. You showed us parts of your lives, your kids, mothers, fathers and husbands or wives, there were even some that had their donors with them too. You showed us what is important in life and by doing this you helped increase the Marrow Registry by 15 people.
Fifteen extra chances for everyone needing a donor. I know its not as many as I would have liked....... that number is closer to 5000, but it’s 15 chances extra - thats wonderful! And I know that all of those that signed up on Saturday will tell at least one other and so it will go on and on and one day maybe it will be a normal thing to do when we come of age - get on the register.
Alta, from The National Marrow Donor Program is wonderful. She was so easy to chat with, has lots of fascinating things to share and easily engaged with people who came in just for an ice cream and handed out information books to those who needed to think about joining. It was wonderful to share the afternoon with someone so upbeat and cheerful and full of positivity.
The “Vein Ladies” on the Blood Assurance bus just seemed to have a blast all the way through. Every time I went on board to get some photographs, there they were, full of laughter, joking and warmth and sometimes hanging out of the back windows chatting the the guys outside (see pictures below). They really made everyone feel totally at home and even promised to sharpen a needle for me as I am a baby when it comes to those sharp things. Well it turned out that I could not donate blood anyway as I had surgery while living in South Africa. What a disappointment! Ok, ok - I will admit to a slight feeling of relief at not having to get jabbed but what a pity that a surgery over 20 years ago would eliminate me from ever donating blood here. I would have donated if I could - even had my I.D. ready. I am already a card carrying member of the NMDP - that sounds so good!
So the day was a success - double digit donors and all. 19 blood and 15 marrow donors. It’s a day that has started many a conversation especially amongst the younger group that came to sign up and also has kindled some ideas in my head for a future donor drive.
It was Adrian and his determination to do what is right, that got me off my butt to do this donor drive. Yes, I could have done it because of Steven, but I had not yet done so. Adrian definitely pushed me out of my comfort zone to do this. I think that the idea that he started, the education of the younger generation, is what will carry all donor drives to true and great success. Adrian’s Army is world wide, can be put into effect by speaking to just one more person, by holding a donor drive or by doing the many available things that can be done to spread the word about the need for donors. Talk to just one more person.........
Being out of my comfort zone while putting this donor drive together was scary, frustrating and disappointing at times..... but mostly it was wonderful! There is nothing quite like spending a day surrounded by people who want to make the world a better place, who are prepared to go through some discomfort to make a difference and who do this with a wish that they ‘get picked”!
A really big Thank You to everyone who signed up on the Marrow Registry or donated blood - you are true lifesavers! Thanks to everyone that helped, supported and encouraged, listened to my fears and gripes over the weeks running up to Saturday. Thanks to those who sent me your photographs, to Kays Kastles, Amber from Blood Assurance , Alta and Carla from NMDP and The Vein Ladies! You were all awesome and it’s you that made this happen.
Love and light
Annie









So - as we all know, one little ant cannot do much on their own, but when we belong to an army, anything is possible.........and I now consider myself one of "Adrian's Army" and know that as long as we try, we will make a difference in some way.